In the CDH6-low kidney nephroblastoma PDX model, CUSP06 exhibited complete tumor growth inhibition (130% TGI vs. IgG-T1000-e control) whereas the R-DXd showed little antitumor activity (23% TGI vs. IgG-DXd control). This evidence concerns the gene CDH6 and Nephroblastoma.